Cargando…
Telmisartan Activates PPARδ to Improve Symptoms of Unpredictable Chronic Mild Stress-Induced Depression in Mice
Major depression is a common mental disorder that has been established to be associated with a decrease in serotonin and/or serotonin transporters in the brain. Peroxisome proliferator-activated receptor δ (PPARδ) has been introduced as a potential target for depression treatment. Telmisartan was re...
Autores principales: | Li, Yingxiao, Cheng, Kai-Chun, Liu, Keng-Fan, Peng, Wen-Huang, Cheng, Juei-Tang, Niu, Ho-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656622/ https://www.ncbi.nlm.nih.gov/pubmed/29070884 http://dx.doi.org/10.1038/s41598-017-14265-4 |
Ejemplares similares
-
Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
por: Chang, Wei-Ting, et al.
Publicado: (2016) -
Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
por: Cheng, Kai-Chun, et al.
Publicado: (2018) -
Cardiac Peroxisome Proliferator-Activated Receptor δ (PPARδ) as a New Target for Increased Contractility without Altering Heart Rate
por: Chen, Zhih-Cherng, et al.
Publicado: (2013) -
Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ–STAT3 Signaling in Type 1-Like Diabetic Rats
por: Lo, Shih-Hsiang, et al.
Publicado: (2017) -
Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
por: Tsai, Cheng-Chia, et al.
Publicado: (2014)